Katerina Pardali

2.7k total citations
28 papers, 2.2k citations indexed

About

Katerina Pardali is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Katerina Pardali has authored 28 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Immunology and 6 papers in Oncology. Recurrent topics in Katerina Pardali's work include TGF-β signaling in diseases (9 papers), IL-33, ST2, and ILC Pathways (7 papers) and Asthma and respiratory diseases (6 papers). Katerina Pardali is often cited by papers focused on TGF-β signaling in diseases (9 papers), IL-33, ST2, and ILC Pathways (7 papers) and Asthma and respiratory diseases (6 papers). Katerina Pardali collaborates with scholars based in Sweden, Netherlands and United Kingdom. Katerina Pardali's co-authors include Aristidis Moustakas, Dimitris Kardassis, Carl-Henrik Heldin, Akira Kurisaki, Peter ten Dijke, Anita Morén, Carl‐Henrik Heldin, Paraskevi Papakosta, Carl‐Henrik Heldin and Hideki Niimi and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Katerina Pardali

27 papers receiving 2.1k citations

Peers

Countries citing papers authored by Katerina Pardali

Since Specialization

Citations

This map shows the geographic impact of Katerina Pardali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katerina Pardali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katerina Pardali more than expected).

Fields of papers citing papers by Katerina Pardali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katerina Pardali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katerina Pardali. The network helps show where Katerina Pardali may publish in the future.

Co-authorship network of co-authors of Katerina Pardali

This figure shows the co-authorship network connecting the top 25 collaborators of Katerina Pardali. A scholar is included among the top collaborators of Katerina Pardali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katerina Pardali. Katerina Pardali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	T2 cytokine-driven alarmin and antiviral responses in asthma: insights into immune modulation and the role of IL-4Rα targeting 2025 ·Frontiers in Allergy ·(unknown), Juan José Nieto‐Fontarigo, Katerina Pardali, Stephen Delaney, Henric Olsson, Lena Uller	0
2	Inhibition of IL-4Rα reduces CCL26 in bronchial epithelial cells from COPD patients 2025 ·ERJ Open Research ·(unknown), Juan José Nieto‐Fontarigo, (unknown), (unknown), Samuel Cerps, Katerina Pardali, Stephen Delaney, Lena Uller	1
3	Phenotype-specific therapeutic efficacy of ilofotase alfa in patients with sepsis-associated acute kidney injury 2024 ·Critical Care ·Niklas Bruse, Katerina Pardali, Maarten C. Kraan, Matthijs Kox, Peter Pickkers, (unknown)	4
4	A MALT1 inhibitor suppresses human myeloid DC, effector T-cell and B-cell responses and retains Th1/regulatory T-cell homeostasis 2020 ·PLoS ONE ·Céline Dumont, Ulf Sivars, (unknown), Lina Odqvist, Johan Mattsson, Amy DeMicco, Katerina Pardali, Gustav Johansson, (unknown), Rhona J. Cox, Frank Seeliger, Marie Larsson, Ulf Gehrmann, (unknown), Outi Vaarala	18
5	A Phase 2a, Double-Blind, Placebo-controlled Randomized Trial of Inhaled TLR9 Agonist AZD1419 in Asthma 2020 ·American Journal of Respiratory and Critical Care Medicine ·Ioannis Psallidas, Vibeke Backer, Piotr Kuna, Robert Palmér, Sofia Necander, (unknown), (unknown), (unknown), Mahdi Hashemi, Per Gustafson, Sara Asimus, Stephen Delaney, Katerina Pardali, (unknown), J.O. Almquist, Sam Jackson, Robert L. Coffman, (unknown), Tariq Sethi	17
6	p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells 2020 ·Scientific Reports ·(unknown), (unknown), Katerina Pardali, Matthias Gaestel, J. Simon C. Arthur	32
7	Immunometabolism pathways as the basis for innovative anti-viral strategies (INITIATE): A Marie Sklodowska-Curie innovative training network 2020 ·Virus Research ·Bernadette van den Hoogen, Angela Santoni, Giuseppe Sciumè, Andrew Bowie, Cliona O’Farrelly, Luke O'neill, Marit W. Anthonsen, Katerina Pardali, Simon Young, Andreas Bergthaler, Nicolas Manel, Roland Zahn, Marjolein Kikkert, Eric J. Snijder, Frank J. M. van Kuppeveld, Ron A. M. Fouchier, John Hiscott	2
8	Activation of group 2 innate lymphoid cells after allergen challenge in asthmatic patients 2019 ·Journal of Allergy and Clinical Immunology ·Carla Winkler, Thomas Hochdörfer, Elisabeth Israelsson, (unknown), (unknown), Kristofer Thörn, Daniel Muthas, (unknown), (unknown), Meike Müller, Jenny Mjösberg, Outi Vaarala, Jens M. Hohlfeld, Katerina Pardali	71
9	An Angle on MK2 Inhibition—Optimization and Evaluation of Prevention of Activation Inhibitors 2019 ·ChemMedChem ·(unknown), (unknown), Emma Evertsson, (unknown), (unknown), Hans Lönn, (unknown), Helena Käck, (unknown), (unknown), Jianming Liu, (unknown), Johan Karlsson, Arjan Snijder, Katerina Pardali, Jan Andersson, (unknown), Mickael Mogemark	4
10	Expression of c‐Kit discriminates between two functionally distinct subsets of human type 2 innate lymphoid cells 2019 ·European Journal of Immunology ·Thomas Hochdörfer, Carla Winkler, Katerina Pardali, Jenny Mjösberg	64
11	Late Breaking Abstract - Multiple ascending dose study of the inhaled IL-4Ra antagonist, AZD1402/PRS-060, in mild asthmatics demonstrates robust FeNO reduction and a promising clinical profile for the treatment of asthma 2019 ·Ingmar Bruns, (unknown), George Mensing, (unknown), Katerina Pardali, (unknown), (unknown), (unknown), Marita Olsson, Cyrus Ghobadi, (unknown), (unknown), Nicholas Farinola, (unknown), (unknown)	4
12	AZD1402/PRS-060, an inhaled Anticalin® IL-4Ra antagonist, potently inhibits IL-4 induced functional effects in human whole blood, which can be employed translationally in clinical studies 2018 ·Katerina Pardali, (unknown), (unknown), Gabriele Matschiner, (unknown)	2
13	Polymorphisms in the multidrug-resistance 1 gene related to glucocorticoid response in rheumatoid arthritis treatment 2017 ·Rheumatology International ·(unknown), Katerina Pardali, Maarten C. Kraan, A.C. Marijnissen, (unknown), Marita Olsson, J. W. J. Bijlsma, Floris P. J. G. Lafeber, Ruth Fritsch‐Stork	17
14	Profiling Cellular Protein Complexes by Proximity Ligation with Dual Tag Microarray Readout 2012 ·PLoS ONE ·Maria Hammond, Rachel Yuan Nong, Olle Ericsson, Katerina Pardali, Ulf Landegren	18
15	Intercellular Variation in Signaling through the TGF-β Pathway and Its Relation to Cell Density and Cell Cycle Phase 2012 ·Molecular & Cellular Proteomics ·Agata Zieba, Katerina Pardali, Ola Söderberg, (unknown), (unknown), Aristidis Moustakas, Carl‐Henrik Heldin, Ulf Landegren	24
16	Functional role of Meox2 during the epithelial cytostatic response to TGF‐β 2007 ·Molecular Oncology ·Ulrich Valcourt, Sylvie Thuault, Katerina Pardali, Carl‐Henrik Heldin, Aristidis Moustakas	29
17	Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer 2006 ·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Katerina Pardali, Aristidis Moustakas	445
18	Smad pathway‐specific transcriptional regulation of the cell cycle inhibitor p21^WAF1/Cip1 2005 ·Journal of Cellular Physiology ·Katerina Pardali, Marcin Kowanetz, Carl‐Henrik Heldin, Aristidis Moustakas	92
19	Mechanisms of TGF-β signaling in regulation of cell growth and differentiation 2002 ·Immunology Letters ·Aristidis Moustakas, Katerina Pardali, (unknown), Carl-Henrik Heldin	440
20	SMAD Proteins Transactivate the Human ApoCIII Promoter by Interacting Physically and Functionally with Hepatocyte Nuclear Factor 4 2000 ·Journal of Biological Chemistry ·Dimitris Kardassis, Katerina Pardali, Vassilis I. Zannis	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact